← Open Payments lookup

WHITNEY WASHINGTON: Open Payments

NPI 1063005718 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,496 in 129 payments from 37 companies in 2025. Trend: 2023 $859 · 2024 $2,050 · 2025 $3,496

Food & beverage: $3,496
CompanyPaymentsAmount
Janssen Biotech, Inc.15$336
Genentech USA, Inc.11$254
Novartis Pharmaceuticals Corporation9$246
GlaxoSmithKline, LLC.10$241
AstraZeneca Pharmaceuticals LP8$184
Merck Sharp & Dohme LLC7$172
E.R. Squibb & Sons, L.L.C.4$142
Astellas Pharma US Inc6$138
Daiichi Sankyo Inc.5$131
ViiV Healthcare Company1$125

Products named: Itovebi, OPDIVO, ENHERTU, XTANDI, KEYTRUDA, TALVEY, RYBREVANT, JEMPERLI.

Industry payments across LA — which companies pay providers there.